Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2016 - 2026)
Neuroone Medical Technologies (NMTC) reported Gains from Investment Securities of $84135.0 for Q1 2026, up 121.55% year-over-year from $37975.0 in Q1 2025, and up 137.77% sequentially from -$222740.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Gains from Investment Securities (2016 - 2026) Analysis & Trends
Neuroone Medical Technologies has disclosed Gains from Investment Securities across 11 years of filings, most recently posting $84135.0 for Q1 2026.
- Quarterly Gains from Investment Securities rose 121.55% year-over-year to $84135.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$544042.0 (up 24.78% YoY) and the FY2025 annual result came in at $1.0 million, down 63.97% from the prior year.
- Gains from Investment Securities climbed to $84135.0 in Q1 2026, from -$222740.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $1.2 million in Q1 2024 and bottomed at -$390351.0 in Q1 2025.
- The 5-year median for Gains from Investment Securities is -$9948.0 (2025), against an average of $13126.6.
- The widest YoY moves for Gains from Investment Securities: up 8867.37% in 2024, down 808.08% in 2024.
- Neuroone Medical Technologies' Gains from Investment Securities stood at $97536.0 in 2022, then slumped by 43.61% to $55000.0 in 2023, then slumped by 808.08% to -$389445.0 in 2024, then surged by 42.81% to -$222740.0 in 2025, then soared by 137.77% to $84135.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $84135.0, -$222740.0, and -$9948.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 26.73 Mn | 23.93 Mn | 990,264.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84,135.00 |
| Mar 31, 2026 | 84,135.00 |
| Dec 31, 2025 | -222,740.00 |
| Dec 31, 2025 | -222,740.00 |
| Sep 30, 2025 | -9,948.00 |
| Sep 30, 2025 | -9,948.00 |
| Jun 30, 2025 | -319,625.00 |
| Jun 30, 2025 | -319,625.00 |
| Mar 31, 2025 | -390,351.00 |
| Mar 31, 2025 | -390,351.00 |
| Dec 31, 2024 | -389,445.00 |
| Dec 31, 2024 | -389,445.00 |
| Sep 30, 2024 | 9,829.00 |
| Sep 30, 2024 | 9,829.00 |
| Jun 30, 2024 | 46,720.00 |
| Jun 30, 2024 | 46,720.00 |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 55,000.00 |
| Dec 31, 2023 | 55,000.00 |